Artemis Q4 Revenue up 7%, EBITDA Rises 21%, Net Profit Jumps 60%
14 May 2025
2 Min Read
CW Team
The Board of Directors of Artemis Medicare Services today approved the company鈥檚 audited financial results for the 4th quarter (Jan to Mar) and 12M (Apr to Mar) for the financial year 2024 鈥� 25.
For the quarter ended March 31, 2025 Artemis Medicare Services, on a consolidated level, registered a gross revenue of Rs 2,521 Million, an increase of 7.0 per cent over the same period last fiscal. For the fiscal year (April 鈥� March), the company鈥檚 gross revenue closed at Rs 9,819 Million, an increase of 6.5 per cent over the same period last fiscal. The Board of Directors have recommended a final dividend of 45 per cent per Equity Share of face value of Re 1 each for FY25, subject to the approval of the shareholders at the ensuing Annual General Meeting (AGM) of the Company.
Commenting on the company鈥檚 performance, Onkar Kanwar, Chairman, Artemis Medicare Services said 鈥淎rtemis concluded FY25 on a strong and positive trajectory, delivering consistent performance and steady growth across the year. We have continued to advance in both clinical excellence and operational capabilities, reaffirming our commitment to provide high-quality, accessible healthcare to the communities we serve. During the year we also inaugurated our third tower, which will be commissioned in a phase-wise manner to accommodate the increasing demand from our growing patient base.
To fuel our next growth phase, we raised Rs 3.30 billion from the International Finance Corporation (IFC), enabling strategic expansion across Delhi NCR and select Tier 2 cities through both brownfield and greenfield projects. The Board has approved a long-term Operations & Management and Medical Services Agreement for a 300+ bed super-speciality hospital in Raipur. This deal marks a key step in expanding our footprint in Central India and reinforces our mission to deliver advanced healthcare solutions across geographies. As we look ahead, our unwavering focus remains on creating long-term value for our patients, shareholders, and employees, while building Artemis into one of India鈥檚 most trusted and respected healthcare brands.鈥�
The Board of Directors of Artemis Medicare Services today approved the company鈥檚 audited financial results for the 4th quarter (Jan to Mar) and 12M (Apr to Mar) for the financial year 2024 鈥� 25.For the quarter ended March 31, 2025 Artemis Medicare Services, on a consolidated level, registered a gross revenue of Rs 2,521 Million, an increase of 7.0 per cent over the same period last fiscal. For the fiscal year (April 鈥� March), the company鈥檚 gross revenue closed at Rs 9,819 Million, an increase of 6.5 per cent over the same period last fiscal. The Board of Directors have recommended a final dividend of 45 per cent per Equity Share of face value of Re 1 each for FY25, subject to the approval of the shareholders at the ensuing Annual General Meeting (AGM) of the Company.Commenting on the company鈥檚 performance, Onkar Kanwar, Chairman, Artemis Medicare Services said 鈥淎rtemis concluded FY25 on a strong and positive trajectory, delivering consistent performance and steady growth across the year. We have continued to advance in both clinical excellence and operational capabilities, reaffirming our commitment to provide high-quality, accessible healthcare to the communities we serve. During the year we also inaugurated our third tower, which will be commissioned in a phase-wise manner to accommodate the increasing demand from our growing patient base.To fuel our next growth phase, we raised Rs 3.30 billion from the International Finance Corporation (IFC), enabling strategic expansion across Delhi NCR and select Tier 2 cities through both brownfield and greenfield projects. The Board has approved a long-term Operations & Management and Medical Services Agreement for a 300+ bed super-speciality hospital in Raipur. This deal marks a key step in expanding our footprint in Central India and reinforces our mission to deliver advanced healthcare solutions across geographies. As we look ahead, our unwavering focus remains on creating long-term value for our patients, shareholders, and employees, while building Artemis into one of India鈥檚 most trusted and respected healthcare brands.鈥�
Next Story
Dassault To Build Falcon Jets In India With Reliance
Reliance Infrastructure Ltd鈥檚 subsidiary, Reliance Aerostructure, has signed an agreement with France鈥檚 Dassault Aviation to manufacture Falcon 2000 business jets in India, with the first batch expected to roll out from its Nagpur facility by 2028. This marks the first time a Falcon aircraft will be entirely built outside France.The announcement sent Reliance Infrastructure shares surging, hitting the 5 per cent upper circuit on the BSE. Anil Ambani, Chairman of Reliance Group, hailed the agreement as a 鈥渟ymbol of India鈥檚 technological and manufacturing strength鈥�, adding that it aims..
Next Story
INDEA Lays Foundation for India鈥檚 First Auto Design School
The Indian School for Design of Automobiles (INDEA), the country鈥檚 first institute focused solely on automobile design and management, held its foundation stone ceremony at XLRI Delhi-NCR. The event was graced by Union Minister for Road Transport and Highways, Nitin Gadkari, who virtually unveiled the stone as Chief Guest.INDEA aims to become a premier talent hub, driving innovation in the Indian automotive sector. The school will focus on advanced design, mobility solutions, and sustainable practices, playing a vital role in shaping India鈥檚 transition from a cost-driven to a quality-led a..
Next Story
Karnataka Launches Global Innovation Hub at Airport City
The Government of Karnataka, in collaboration with Bengaluru Airport City Limited (BACL) and ANSR, has launched a global innovation hub named District I at Bengaluru Airport City's business park. The initiative aims to elevate India鈥檚 innovation ecosystem to a global scale by fostering collaboration among startups, academia, enterprises, and government bodies.District I will serve as a platform for deep-tech entrepreneurship, enterprise innovation, and commercialisation of academic research. It brings together Global Capability Centres (GCCs), IT firms, corporate labs, startups, venture capi..
